Pfizer To Seek FDA OK For COVID-19 Vaccine 'Within Days'
The vaccine was found to be 95% effective in an updated study analysis. Safety data required by the Food and Drug Administration showed no serious concerns, the company said.
Pfizer is ready to ask the Food and Drug Administration to authorize emergency use of the company's COVID-19 vaccine, after an updated analysis of the clinical trial data found the vaccine to be 95% effective.
The of the vaccine study had indicated the vaccine was more than 90% effective.
